Silver-coated copper paste replaces most of the silver in a solar cell's conductive paste with a copper core, keeping only a thin silver shell to preserve conductivity and prevent oxidation. It matters because silver is one of the largest non-silicon cost inputs in cell manufacturing, and copper is far cheaper and more abundant. The patent evidence in this dataset shows this approach concentrated in China, with the most-cited families specifically targeting heterojunction and TOPCon cell architectures.

Coverage is fragmented rather than blocked by a single owner: the leading assignee in this dataset holds only 2 of 24 records, and the top 5 assignees combined account for just 25.0% of all records in scope. That means no one company controls the core chemistry, but specific formulations, curing processes and plating methods within it may still be individually claimed. A freedom-to-operate search against the specific process steps you plan to use is still necessary.

The filing trend in this dataset rose unevenly from zero in 2017 to a peak of 7 in 2024, but the 2022 midpoint was only 2 records, showing growth has not compounded steadily. This pattern is typical of a technology still working out its basic chemistry and process steps rather than one in a scaling phase. Because publication lags filing by around 18 months, the most recent year's low count likely understates real activity rather than signalling a slowdown.

The IPC composition shows heavy coverage of conductor and semiconductor-device classes but only single-record coverage of coating, cleaning, and electroplating subclasses. That imbalance suggests oxidation-barrier coatings, seedless plating processes and copper electrode surface treatments are comparatively under-claimed relative to the paste formulations themselves. Anyone filing in these adjacent process areas should check the thin subclasses directly rather than relying on the paste-chemistry crowding as a proxy for overall field density.

China accounts for 22 of the tracked receiving-office filings in this dataset, against 1 in Japan and 1 filed through the PCT route. That skew means Chinese patent literature and Chinese-language prior art form the practical baseline for any clearance or invalidity search in this field, even for companies planning to manufacture or sell elsewhere. Filers pursuing protection outside China should still expect examiners to cite Chinese prior art given how concentrated the filings are there.